These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24564348)

  • 1. Nanotechnology: a magic bullet for HIV AIDS treatment.
    Kumar L; Verma S; Prasad DN; Bhardwaj A; Vaidya B; Jain AK
    Artif Cells Nanomed Biotechnol; 2015 Apr; 43(2):71-86. PubMed ID: 24564348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.
    Sharma P; Garg S
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):491-502. PubMed ID: 19931328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.
    Date AA; Destache CJ
    Biomaterials; 2013 Aug; 34(26):6202-28. PubMed ID: 23726227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.
    das Neves J; Amiji MM; Bahia MF; Sarmento B
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):458-77. PubMed ID: 19914314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards nanomedicines for neuroAIDS.
    Sagar V; Pilakka-Kanthikeel S; Pottathil R; Saxena SK; Nair M
    Rev Med Virol; 2014 Mar; 24(2):103-24. PubMed ID: 24395761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
    Muthu MS; Singh S
    Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in nanotechnology for diagnosis and treatment of tuberculosis.
    Banyal S; Malik P; Tuli HS; Mukherjee TK
    Curr Opin Pulm Med; 2013 May; 19(3):289-97. PubMed ID: 23429097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel liquid formulation developed to deliver nanomedicine treatment for HIV/AIDS.
    Nanomedicine (Lond); 2010 Jul; 5(5):684. PubMed ID: 20662639
    [No Abstract]   [Full Text] [Related]  

  • 11. Nanotechnological carriers for cancer chemotherapy: the state of the art.
    Estanqueiro M; Amaral MH; Conceição J; Sousa Lobo JM
    Colloids Surf B Biointerfaces; 2015 Feb; 126():631-48. PubMed ID: 25591851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano drug-delivery systems for management of AIDS: liposomes, dendrimers, gold and silver nanoparticles.
    Asl FD; Mousazadeh M; Taji S; Bahmani A; Khashayar P; Azimzadeh M; Mostafavi E
    Nanomedicine (Lond); 2023 Feb; 18(3):279-302. PubMed ID: 37125616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of polymeric nanoparticles in AIDS treatment and prevention.
    Khalil NM; Carraro E; Cótica LF; Mainardes RM
    Expert Opin Drug Deliv; 2011 Jan; 8(1):95-112. PubMed ID: 21143001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology: a versatile aid in our fight against AIDS.
    Banerjee R
    Nanomedicine (Lond); 2013 May; 8(5):675-7. PubMed ID: 23656261
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.
    Edagwa BJ; Zhou T; McMillan JM; Liu XM; Gendelman HE
    Curr Med Chem; 2014; 21(36):4186-98. PubMed ID: 25174930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nanotechnology in HIV/AIDS treatment: potential to overcome the viral reservoir challenge.
    Amiji MM; Vyas TK; Shah LK
    Discov Med; 2006 Aug; 6(34):157-62. PubMed ID: 17234137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS.
    Singh G; Pai RS; Mustafa S
    Crit Rev Ther Drug Carrier Syst; 2015; 32(6):503-33. PubMed ID: 26559551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
    Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.